SynCardia New Gen Product Event

Join us for the unveiling of SynCardia's latest innovation, the first and only FDA-approved new generation SynCardia Total Artificial Heart (TAH), in a gathering that will spotlight advances in medical technology and foster industry collaboration. This exclusive event, hosted by the US Unicorn Foundation (USUF) and SynCardia, offers participants a deep dive into SynCardia’s cutting-edge solutions, insightful presentations from industry leaders, and invaluable networking opportunities.

Special Offer

The first 30 registrants who follow USUF and send us a screenshot will receive a promo code for FREE admission.

Event Schedule

11:00 AM - 11:30 AM: Check-In

• Participants check in at the entrance, receive event materials, enjoy welcome drinks, and network.

11:30 AM - 11:45 AM: Welcome and USUF Introduction

• Introduce the mission, vision, and supported innovative companies of the US Unicorn Foundation.
• Highlight the importance of USUF in facilitating the development of companies before their IPO.

11:45 AM - 12:00 PM: SynCardia Introduction

• Overview the founding background, technological innovations, and industry leadership of SynCardia.
• Emphasize its significance in the medical device sector.

12:00 PM - 12:25 PM: Guest Introductions

• Invite guests to introduce their organizations and their collaboration with SynCardia.

- Richard Fang; Investor, Hunniwell Lake Ventures:

Richard is the lead investor at SynCardia, and he will discuss the company's contributions and collaboration cases with SynCardia.

- Jennifer Scutti, The Benchmark Company:

Jennifer is currently the Managing Director at Benchmark, serving in the New York metropolitan area since September 2023. She’s in the CM industry for over 30 years. Benchmark provides comprehensive investment banking and brokerage services, focusing on helping growth companies achieve long-term success through capital raising, strategic consulting, and institutional support.

- Michael J. Blankenship, Winston & Strawn LLP:

Mike is the Managing Partner of the Houston office of Winston & Strawn and Co-Chair of the firm's Capital Markets practice and a member of the Executive Committee. He focuses on corporate finance and securities law, covering securities offerings, public company advisory, SPAC transactions, private equity and venture capital, mergers and acquisitions, and corporate governance matters.

12:25 PM - 1:00 PM Speech by SynCardia CEO Patrick

• Present promotional materials for the new generation : Patrick, CEO of SynCardia TAH product.

• Explain the product's innovative features, market potential, and the company's long-term vision.

1:00 PM - 1:20 PM Q&A Session

• Audience can ask questions regarding Patrick's speech and the STAH product.
• Provide an opportunity for in-depth discussions and understanding potential opportunities of the product.

1:20 PM - 2:00 PM Networking Time (Food and Drinks)

• Provide light refreshments and drinks for participants, creating a relaxed networking atmosphere.

• Encourage interaction between guests and participants to foster collaboration opportunities.

Event Venue & Nearby Stays

Hyatt Regency San Francisco, 5 Embarcadero Center, San Francisco, United States